Company intelligence / Profile preview

Chengdu Shang-Li Aesthetic

Chengdu, Sichuan, China600200.com ↗
Ownership
Private
Development stage
Clinical
01

Overview

Chengdu Shang-Li Aesthetic holds exclusive sales rights in China to high-end injection-use cross-linked sodium hyaluronate gel products from South Korea's Humedix. These have entered clinical registration. The company also develops its own recombinant humanized type III collagen injectables through a joint lab with Zhejiang University International Science and Innovation Center. Its first private label product "As A BABY" has launched commercially. The company covers a range of medical aesthetic injectables including fillers, lipolytic solutions, and supplements.

Therapeutic areas
Dermatology
Modalities
Hyaluronic acid fillerRecombinant collagenCollagen supplementsLipolytic solution
Industry
Biotech
02

Drug pipeline

1 asset

As A BABY

Commercial
Indications
Aesthetic medicine
03

Partnerships

Exclusive distribution partnership with Humedix (South Korea) for cross-linked sodium hyaluronate gel injectables in Chinajoint laboratory collaboration with Zhejiang University International Science and Innovation Center on recombinant humanized type III collagen synthesis technology

Beyond the preview

Go deeper on Chengdu Shang-Li Aesthetic.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Chengdu Shang-Li Aesthetic.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call